Infrastructure for Personalized Medicine at Partners HealthCare

DSpace/Manakin Repository

Infrastructure for Personalized Medicine at Partners HealthCare

Citable link to this page


Title: Infrastructure for Personalized Medicine at Partners HealthCare
Author: Weiss, Scott Tillman; Shin, Meini

Note: Order does not necessarily reflect citation order of authors.

Citation: Weiss, Scott, and Meini Shin. 2016. “Infrastructure for Personalized Medicine at Partners HealthCare.” JPM 6 (1) (February 27): 13. doi:10.3390/jpm6010013.
Full Text & Related Files:
Abstract: Partners HealthCare Personalized Medicine (PPM) is a center within the Partners HealthCare system (founded by Massachusetts General Hospital and Brigham and Women’s Hospital) whose mission is to utilize genetics and genomics to improve the care of patients in a cost effective manner. PPM consists of five interconnected components: (1) Laboratory for Molecular Medicine (LMM), a CLIA laboratory performing genetic testing for patients world-wide; (2) Translational Genomics Core (TGC), a core laboratory providing genomic platforms for Partners investigators; (3) Partners Biobank, a biobank of samples (DNA, plasma and serum) for 50,000 Consented Partners patients; (4) Biobank Portal, an IT infrastructure and viewer to bring together genotypes, samples, phenotypes (validated diagnoses, radiology, and clinical chemistry) from the electronic medical record to Partners investigators. These components are united by (5) a common IT system that brings researchers, clinicians, and patients together for optimal research and patient care.
Published Version: doi:10.3390/jpm6010013
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at
Citable link to this page:
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)


Search DASH

Advanced Search